-
Non Regulatory June 10, 2021First Patient enrolled in the SAKK Investigator-Initiated Phase 1b trial of Docetaxel Micellar in Advanced Prostate Cancer
-
Non Regulatory June 9, 2021Oasmia Provides a R&D Update on its Technology Platforms
-
Non Regulatory June 2, 2021Oasmia to present at Aktiespararna’s Småbolagsdagar on June 9
Oasmia Pharmaceutical published its interim report for the first quarter of 2021 on May 27, 2021, at 08.00 am CEST.
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®